Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results

Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable

(2016) Tiffany W. Liang et al.   JOURNAL OF VASCULAR SURGERY

Hypoxia promotes bone marrow-derived mesenchymal stem cell proliferation through apelin/APJ/autophagy pathway

(2015) L. Li et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Safety and Efficacy of Autologous Cell Therapy in Critical Limb Ischemia: A Systematic Review

(2013) Eric Benoit et al.   CELL TRANSPLANTATION

Clinical Outcome After Extended Endovascular Recanalization in Buerger’s Disease in 20 Consecutive Cases

(2012) Lanfroi Graziani et al.   ANNALS OF VASCULAR SURGERY

Timing of Intra-Arterial Neural Stem Cell Transplantation After Hypoxia–Ischemia Influences Cell Engraftment, Survival, and Differentiation

(2012) Sahar Rosenblum et al.   STROKE

Development of pluripotent stem cells for vascular therapy

(2012) Katharina S. Volz et al.   VASCULAR PHARMACOLOGY

Autologous Bone-Marrow Mononuclear Cell Implantation Reduces Long-Term Major Amputation Risk in Patients With Critical Limb Ischemia

(2011) Naomi Idei et al.   Circulation-Cardiovascular Interventions

Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia

(2011) Michael P. Murphy et al.   JOURNAL OF VASCULAR SURGERY

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

(2008) Satoaki Matoba et al.   AMERICAN HEART JOURNAL

Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells

(2008) Vishnu Motukuru et al.   JOURNAL OF VASCULAR SURGERY